[go: up one dir, main page]

AP2138A - Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes. - Google Patents

Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes.

Info

Publication number
AP2138A
AP2138A AP2006003799A AP2006003799A AP2138A AP 2138 A AP2138 A AP 2138A AP 2006003799 A AP2006003799 A AP 2006003799A AP 2006003799 A AP2006003799 A AP 2006003799A AP 2138 A AP2138 A AP 2138A
Authority
AP
ARIPO
Prior art keywords
compositions
management
treatment
methods
myelodysplastic syndromes
Prior art date
Application number
AP2006003799A
Inventor
Jerome B Zeldis
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Priority to AP2006003799A priority Critical patent/AP2138A/en
Application granted granted Critical
Publication of AP2138A publication Critical patent/AP2138A/en

Links

AP2006003799A 2004-04-14 2004-04-14 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes. AP2138A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AP2006003799A AP2138A (en) 2004-04-14 2004-04-14 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AP2006003799A AP2138A (en) 2004-04-14 2004-04-14 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes.

Publications (1)

Publication Number Publication Date
AP2138A true AP2138A (en) 2010-07-22

Family

ID=43304087

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003799A AP2138A (en) 2004-04-14 2004-04-14 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes.

Country Status (1)

Country Link
AP (1) AP2138A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006712A1 (en) * 1990-10-12 1992-04-30 Amgen Inc. Megakaryocyte maturation factors
US5288487A (en) * 1989-02-28 1994-02-22 Morinaga Milk Industry Co., Ltd. Human monocyte-macrophage-CSF preparations
US6281230B1 (en) * 1996-07-24 2001-08-28 Celgene Corporation Isoindolines, method of use, and pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288487A (en) * 1989-02-28 1994-02-22 Morinaga Milk Industry Co., Ltd. Human monocyte-macrophage-CSF preparations
WO1992006712A1 (en) * 1990-10-12 1992-04-30 Amgen Inc. Megakaryocyte maturation factors
US6281230B1 (en) * 1996-07-24 2001-08-28 Celgene Corporation Isoindolines, method of use, and pharmaceutical compositions

Similar Documents

Publication Publication Date Title
AP2089A (en) Compositions and methods for combination antiviraltherapy
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
EP1718282A4 (en) Methods and compositions for imaging
ZA200703908B (en) Compositions for HCV treatment
IL189795A0 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
MY143799A (en) Compositions and methods for treating diabetes
EP1755733A4 (en) Methods and devices for thermal treatment
IL183581A0 (en) Viscosupplementation devices and compositions
GB0412070D0 (en) Treatment device
IL178786A0 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension
IL178591A0 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
EP1841397A4 (en) Formulations and treatments for trichology
EP1626692A4 (en) Compounds for the treatment of flaviviridae infections
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
EP1744748A4 (en) Method of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myelodysplastic syndromes
EP1885351A4 (en) Methods and compositions for the treatment of pain
GB0415181D0 (en) Compounds for use in the treatment of infection
ZA200804872B (en) Lactam compounds and methods of using the same
EP1562606A4 (en) Methods of using vitamin d compounds in the treatment of myelodysplastic syndromes
GB0417036D0 (en) Compounds, compositions and devices
IL179670A0 (en) Heterocyclic compounds and processes for the preparation thereof
GB0424051D0 (en) Compounds and compositions
AP2138A (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes.
IL179039A0 (en) Method of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
GB0327414D0 (en) Improved floor treatment compositions